Apellis Pharmaceuticals Inc Net Asset Quality Index
Apellis Pharmaceuticals Inc net asset quality index. Apellis Pharmaceuticals Inc (APLS) has a Net Asset Quality Index of 38.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.08 Billion minus total liabilities of $667.61 Million yields net assets of $414.92 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Apellis Pharmaceuticals Inc for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Apellis Pharmaceuticals Inc (2013–2025)
Net asset quality index of Apellis Pharmaceuticals Inc from 2013 to 2025. This chart shows how Apellis Pharmaceuticals Inc's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 38.3%, representing net assets of $414.92 Million against total assets of $1.08 Billion USD. Check Apellis Pharmaceuticals Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Apellis Pharmaceuticals Inc Net Asset Quality Index by Year (2013–2025)
Apellis Pharmaceuticals Inc net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Apellis Pharmaceuticals Inc from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Apellis Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.4% | $370.15 Million | $1.08 Billion | $705.11 Million | ▲ +8.6 pp |
| 2024 | 25.8% | $228.54 Million | $885.05 Million | $656.51 Million | ▲ +1.2 pp |
| 2023 | 24.7% | $194.52 Million | $788.73 Million | $594.21 Million | ▲ +2.3 pp |
| 2022 | 22.3% | $169.87 Million | $760.22 Million | $590.35 Million | ▼ -0.2 pp |
| 2021 | 22.5% | $198.66 Million | $881.76 Million | $683.10 Million | ▲ +1.2 pp |
| 2020 | 21.3% | $204.56 Million | $960.57 Million | $756.01 Million | ▲ +12.5 pp |
| 2019 | 8.8% | $34.23 Million | $389.24 Million | $355.02 Million | ▼ -70.3 pp |
| 2018 | 79.1% | $160.97 Million | $203.53 Million | $42.56 Million | ▼ -2.7 pp |
| 2017 | 81.8% | $148.94 Million | $182.13 Million | $33.19 Million | ▼ -5.0 pp |
| 2016 | 86.7% | $23.79 Million | $27.43 Million | $3.64 Million | ▼ -4.9 pp |
| 2015 | 91.6% | $34.98 Million | $38.18 Million | $3.20 Million | ▼ -0.8 pp |
| 2014 | 92.4% | $13.22 Million | $14.31 Million | $1.08 Million | ▲ +5.5 pp |
| 2013 | 87.0% | $4.52 Million | $5.20 Million | $676.96K | — |